Fibroblast growth factor 2 activation of stromal vascular endothelial growth factor expression and angiogenesis

Laboratory Investigation

Volumn 81, Issue 1, 2001, Pages 61-75

  Claffey, Kevin P ^a   Abrams, Kristin ^b   Shih, Shu Ching ^c   Brown, Lawrence F ^b   Mullen, Andrew ^b   Keough, Martin ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; MATRIGEL; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER GROWTH; CELL INFILTRATION; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; STROMA CELL; TUMOR VASCULARIZATION;

EID: 0035136140     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780212     Document Type: Article

References (91)

1. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma
2. Development of snake antivenom antibodies in chickens and their purification from yolk
3. Sponge-induced angiogenesis in mice and the pharmacological reactivity of the neovasculature quantitated by a fluorimetric method
4. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
5. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121
6. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma
7. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: Implications for coronary angiogenesis
8. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide
9. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies
10. Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells
11. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
12. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
13. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast
14. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
15. The up-regulation of vascular endothelial growth factor in mutated Ha-ras HaCaT cell lines is reduced by a farnesyl transferase inhibitor
16. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
17. Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis
18. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways
19. Mouse model of angiogenesis
20. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms
21. Targeting human prostatic carcinoma through basic fibroblast growth factor receptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance
22. Involvement of endothelial PECAM-1/CD31 in angiogenesis
23. Quantitation and physiological characterization of angiogenic vessels in mice: Effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment
24. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
25. Tumor stroma
26. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma ormation
27. Up-regulation of vascular endothelial growth factor in stromal cells of heman-gioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha
28. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase
29. The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase
30. Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway
31. The role of angiogenesis in tumor growth
32. Switch to the angiogenic phenotype during tumorigenesis
33. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
34. Tumor induction of VEGF promoter activity in stromal cells
35. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool
36. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
37. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells
38. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia
39. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway
40. VEGF induces hyperpermeability by a direct action on endothelial cells
41. Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat
42. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A
43. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17 beta-oestradiol
44. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate
45. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer
46. A model of angiogenesis in the mouse cornea
47. Retention of fibroblast growth factor 3 in the Golgi complex may regulate its export from cells
48. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody
49. Spatial and temporal expression of angiogenic molecules during tumor growth and progression
50. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts
51. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor
52. Cloning of a ribosome-associated protein cDNA, 36B4
53. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density
54. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
55. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
56. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells
57. Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer
58. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor
59. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
60. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
61. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
62. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
63. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
64. The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis
65. Mutant ras oncogenes upregulate VEGF expression: Implications for induction and inhibition of tumor angiogenesis
66. Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis
67. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: The gelatin sponge/chorioallantoic membrane assay
68. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis
69. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
70. Vascular permeability factor, tumor angiogenesis and stroma generation
71. Purification of a vascular permeability factor (VPF) from tumor cell conditioned medium
72. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor
73. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin
74. Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF)
75. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells
76. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
77. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
78. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia
79. Immunohistochemical study of fibroblast growth factor-2 (FGF-2) and fibroblast growth factor receptor (FGF-R) in experimental squamous cell carcinoma of rat submandibular gland
80. Expressions of basic fibroblast growth factor and fibroblast growth factor receptor mRNA in soft tissue tumors by in situ hybridization
81. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
82. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma
83. PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis
84. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma [see comments]
85. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
86. A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors. Studies on the effects of carriers, PBS, angiogenin, and bFGF
87. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane
88. Apoptosis and angiogenesis: Two promising tumor markers in breast cancer
89. Expression of FGF1 and FGFR1 in human melanoma tissues
90. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer
91. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis